Skip to main content

Table 3 Adverse events reported during treatment

From: Microelimination of hepatitis C in patients with chronic hemolytic anemias: a single-center experience

Adverse event Number (%)
No 16 (76.19%)
Dizziness 1 (4.76%)
Anorexia 1 (4.76%)
Sleepiness 1 (4.76%)
Menorrhagia 1 (4.76%)
Sickle cell crisis 1 (4.76%)
Decompensation 1 (4.76%)